Julie G. Anderson

Roche Pharmaceuticals provides research and development services in the fields of pharmaceuticals and diagnostics. It also provides diagnostics and drugs for cancer and transplantation. The company is headquartered in Nutley, NJ.

Adheron Therapeutics, Inc. discovers and develops therapeutic drugs. The firm offers Cadherin-11 antagonists for the treatment of rheumatoid arthritis and fibrotic diseases including pulmonary fibrosis and skin fibrosis. The company was founded by David Lee, Michael B. Brenner, and David L. Castaldi in 2006 and is headquartered in Berkeley, CA.

Eisai Ltd. (United Kingdom) is a pharmaceutical company based in Hatfield, UK. Part of Eisai Co., Ltd., Eisai Ltd. prioritizes patients and their families by continually improving the benefits that healthcare can provide. The British company was founded in 1988 and Gary Bryan Hendler has been the CEO of the company since 2008.

Svelte Medical Systems, Inc. develops balloon expandable stents. It offers balloon control band technologies, hybrid stent design and integrated delivery systems. The firm has locations in Brussels, New Providence and Sao Paulo. The company was founded by Robert E. Fischell, David R. Fischell and Tim A. Fischell in 2007 and is headquartered in New Providence, NJ.

Part of Fresenius Medical Care AG, Xcorporeal Operations, Inc. is a company that distributes medical devices. The company is based in Dover, DE. The CEO of the company is Kelly J. McCrann. Xcorporeal Operations was acquired by Fresenius Securities, Inc. from Xcorporeal, Inc. on March 31, 2010 for $88 million.

Bullet Biotechnology, Inc. develops active immunotherapies to stimulate a person’s own immune system to overcome diseases. Its technology educates the immune system to targeting specific cells that are causing disease. The firm's pipeline includes therapeutic vaccines for cancer, multi-specific antibody capsid products, therapeutic vaccines for autoimmune diseases, and other vaccines. The company was founded by Diego Fonstad, James R. Swartz, Willie Quinn and Thomas Theriault in September 2011 and is headquartered in Redwood City, CA.

BDO USA LLP operates as an accounting, auditing, and bookkeeping firm. It offers advisory; audit and assurance; digital; and tax services. The company was founded by Maximillian L. Seidman in 1910 and is headquartered in New York, NY.

Hoffmann-La Roche, Inc. manufactures pharmaceutical drugs. Its products include influenza fighter Tamiflu, controversial acne medication Accutane, HIV inhibitor Fuzeon, obesity drug Xenical, and hepatitis C therapy Pegasys. The company was founded in 1896 Roche and is headquartered in Nutley, NJ.

Triathlon Medical Venture Partners LLC (Triathlon Medical Venture) is a venture capital firm founded in 2004 by Dennis Costello and John Rice. The firm is headquartered in Cincinnati, Ohio with additional offices in Indianapolis and Louisville.

Intellect Capital Ventures LLC (Intellect Cap Ventures) is a venture capital subsidiary of Intellect Partners LLC founded in 2000. The firm is headquartered in Los Angeles, California.

Michigan Ross Zell Lurie Institute / Venture Capital/ (Zell Lurie Institute) is a venture capital subsidiary of Zell Lurie Institute for Entrepreneurial Studies Studies founded in 1997 by Samuel Zell, Ann Lurie and Robert H. Lurie. The firm is headquartered in Ann Arbor, Michigan.

Crede Capital Group LLC (Crede Capital) is a private equity firm founded in 2009. The firm is headquartered Los Angeles.

Priority Health engages in provision of insurance services. It offers health maintenance organization (HMO) plans. The company was founded in 1986 and is headquartered in Grand Rapids, MI.

Panmira Pharmaceuticals LLC provides drug development programs. It develops pharmaceutical products for inflammatory diseases. The company was founded in September 2011 and is headquartered in San Diego, CA.

Acuitas Capital Group, LLC provides investment services. The private company is based in Santa Monica, CA.

NeurMedix, Inc. is a clinical-stage biopharmaceutical company that develops products for the treatment of neurological and neuro-degenerative disorders and certain cancers. NeurMedix is based in San Diego, CA, and was founded by Terren S. Peizer, who has been the CEO since incorporation. The private company's product candidates have completed several pre-clinical and clinical studies, indicating its broad anti-inflammatory effect without evidence of immunosuppression. NeurMedix has invested over $85 million in developing NE3107, and its focus is on diseases with significant unmet medical needs and commercial potential. The company plans to enter clinical trials for the treatment of Parkinson's disease and several oncological indications later this year.

Acuitas Group Holdings LLC functions as an investment holding company. The company is based in Los Angeles, CA.

Part of Deloitte LLP (New York), Monitor Deloitte is a company that provides strategic consulting services. The company is based in Rosslyn, VA. The company was founded by Lene S Schulze.

OcuSub, Inc. engages biotechnology services. It specializes in eye disorder treatment. The company was founded by Mina Patel Sooch, Alan R. Meyer, and William H. Pitlick in 2018 and is headquartered in Farmington Hills, MI.

Adaptive Holdings Ltd. provides technology services. The company is headquartered in George Town, Cayman Islands.

Casperlabs LLC develops block chain platform. The company was founded by Medha Parlikar, Vlad Zamfir, Steven Nerayoff and Mrinal Manohar and is headquartered in Zug, Switzerland.

Part of Kinarus Therapeutics Holding AG, Kinarus AG is a Swiss clinical stage pharmaceutical company that focuses on novel treatments to patients suffering from viral, respiratory and ophthalmic diseases. The company is based in Basel, Switzerland. The company was founded in 2017 by Alexander Bausch, Roger Meier. Alexander Bausch has been the CEO since 2017. Kinarus was acquired by Perfect Holding SA on June 03, 2022.